Galectin Therapeutics Issued Patent for PF Therapy Candidate GR-MD-02

Galectin Therapeutics Issued Patent for PF Therapy Candidate GR-MD-02

Galectin Therapeutics was issued a patent for its lead investigative therapy GR-MD-02 for the treatment of pulmonary fibrosis by the U.S. Patent and Trademark Office (USPTO), the company announced. GR-MD-02 is a carbohydrate-based medicine that binds and stops the action of the galectin-3 protein, which is directly involved in multiple…

Enjoying Every Moment of Summer

e With summer in full swing, I’ve decided to enjoy the special things about the season. I’m trying to be intentional about relishing the good things, instead of going into automatic mode — just surviving every day. Summer food Boysenberry Cobbler (Photo by Kim Fredrickson) My…